Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: A dual-probe microdialysis study in intact conscious rat brain

Neuroscience

Volumn 102, Issue 1, 2001, Pages 113-120

  Ferraro, L ^a   Tomasini, M C ^a   Fernandez, M ^b   Bebe, B W ^a   O'Connor, W T ^c   Fuxe, K ^d   Glennon, J C ^c   Tanganelli, S ^a   Antonelli, T ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Awake rat; Basal ganglia; Motor circuit; SR 48692; Thalamus

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; DOPAMINE 2 RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; RACLOPRIDE; TETRODOTOXIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; 4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN PERFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; GABAERGIC TRANSMISSION; MALE; MICRODIALYSIS; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; THALAMUS;

ANIMALS; CONSCIOUSNESS; DOPAMINE ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MICRODIALYSIS; NEURAL PATHWAYS; NEURONS; NEUROTENSIN; PEPTIDE FRAGMENTS; PYRAZOLES; QUINOLINES; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTENSIN; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TETRODOTOXIN; VENTRAL THALAMIC NUCLEI;

EID: 0035793018     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00448-6     Document Type: Article

References (68)

1. 3H]N-propylnorapomorphine binding sites
2. The functional anatomy of basal ganglia disorders
3. Functional architecture of basal ganglia circuits: Neuronal substrates of parallel processing
4. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens
5. 3H]SR 48692, in the guinea pig brain
6. Effects of neurotensin on DA release and metabolism in the rat striatum and nucleus accumbens: Cross-validation using in vivo voltammetry and microdialysis
7. Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra
8. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalamus
9. Topographical distribution of possible glutamatergic pathways from the prefrontal cortex to the striatum and substantia nigra of the rat
10. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat
11. The neurotensin receptor antagonist SR 48692 decreases extracellular striatal GABA in rats
12. Disinhibition as a basic process in the expression of striatal functions
13. Behavioral effects of neurotensin applied to periventricular structures of rats
14. The current status of neurotensin-dopamine interactions: Issues and speculations
15. Localization of neuropeptide receptor mRNA in rat brain: Initial observations using probes for neurotensin and substance P receptors
16. Neurotensin in human brain: Regional distribution and effects of neurological illness
17. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate
18. Characterization of neurotensin-like immunoreactivity in human basal ganglia: Increased neurotensin levels in substantia nigra in Parkinson's disease
19. Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat
20. The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: Functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop
21. 2 receptors as a major mechanism for the neuroleptic-like action of neurotensin
22. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum
23. The neostriatal mosaic: Multiple levels of compartmental organization
24. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor
25. 2 receptors
26. On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies
27. Biochemistry of somatodendritic dopamine release in substantia nigra: An in vivo comparison with striatal dopamine release
28. Autoradiographic and electrophysiological evidence for the existence of neurotensin receptors on cultured astrocytes
29. Organization of projections from the anterior pole of the nucleus reticularis thalami (NRT) to subdivisions of the motor thalamus: Light and electron microscopic studies in the rhesus monkey
30. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro
31. Neurotensin: Topographical distribution in rat brain by immunohistochemistry
32. Fast estimation of GABA in microdialysis perfusates: Effects of nipecotic acid and 3-mercaptopropionic acid
33. The cortico-nigral projection: Reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat
34. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat - II. Evidence for striatal N-methyl-d-aspartate receptor regulation of striatonigral GABAergic transmission and motor function
35. In vivo release of dopamine during perfusion of neurotensin in substantia nigra of the unrestrained rat
36. Neurotensin-dopamine interactions in the CNS
37. The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: An in vivo microdialysis study
38. 2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions
39. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
40. Turning behavior induced by intrastriatal injection of neurotensin in mice: Sensitivity to non-peptide neurotensin antagonists
41. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals
42. A synaptic currents in the rat substantia nigra pars reticulata
43. Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: An electron microscopic, immunogold analysis in the cat
44. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: Electrophysiological data
45. Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: A microdialysis study in the rat
46. Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence
47. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions
48. Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects
49. A GABA immunocytochemical study of rat motor thalamus: Light and electron microscopic observations
50. Effect of intracerebral administration of somatostatin and neurotensin on posture and movement disorders
51. Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice
52. Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat
53. Convergence of synaptic inputs from the striatum and the globus pallidus onto identified nigrocollicular cells in the rat: A double anterograde labelling study
54. 2 receptors in nigral GABA release
55. Synthesis of peptides by the solid-phase method. 6. Neurotensin, fragments, and analogues
56. Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens
57. Alteration of neurotensin receptors in MPTP-treated mice
58. Characterization of extracellular GABA in the substantia nigra reticulata by means of brain microdialysis
59. Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects
60. A morphological evidence for monosynaptic projections from the nucleus tegmenti pedunculopontinus pars compacta (TPC) to nigrostriatal projection neurons
61. Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: Evidence for the involvement of multiple receptors
62. Biphasic and opposite effects of dopamine and apomorphine on endogenous GABA release in the rat substantia nigra
63. Neurotensin and neurotensin receptors
64. Neurotensin reduces the affinity of dopamine D2 receptors in membranes from post mortem human caudate-putamen
65. Synaptic organization of GABAergic inputs from the striatum and the globus pallidus onto neurons in the substantia nigra and retrorubral field which project to the medullary reticular formation
66. Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area
67. Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis